Blood Glucose Meters Industry Data Book - Point-of-care Glucose Testing Devices, Self-Monitoring & Continuous Blood Glucose Monitors Market Size, Share, Trends Analysis, And Segment Forecasts, 2023 - 2030

Published Date: Jan, 2023
Report ID: sector-report-00116
Format: Electronic (PDF)
Number of Pages: 250

Table of Contents - Sectoral Outlook Report

Chapter 1. Executive Summary
1.1. Market Outlook
1.2. Segment Outlook
1.2.1. Product outlook
1.2.2. End use outlook
1.2.3. Regional outlook
1.3. Competitive Insights
Chapter 2. Market Statistics
2.1. Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the following
2.1.1. Self-monitoring devices
2.1.1.1. Blood glucose meter
2.1.1.2. Testing strips
2.1.1.3. Lancets
2.1.2. Continuous glucose monitoring devices
2.1.2.1. Sensor
2.1.2.2. Transmitter and receiver
2.1.2.3. Insulin pumps
2.2. Point-of-care Glucose Testing: Product Market Size & Forecasts, 2018 to 2030
2.2.1. Accu Check Aviva Meter
2.2.2. Onetouch Verio Flex
2.2.3. i-STAT
2.2.4. Freestyle Lite
2.2.5. Bayer CONTOUR Blood Glucose Monitoring System
2.2.6. True Metrix
2.2.7. Accu-Chek Inform II
2.2.8. StatStrip
2.2.9. Others
2.3. Blood Glucose Meters Market: End Use Estimates & Trend Analysis
2.3.1. Hospitals
2.3.2. Home care
2.3.3. Diagnostic centers
2.4. Blood Glucose Meters Market Estimates & Forecasts, by Region, 2017 - 2030
2.4.1. North America
2.4.1.1. U.S.
2.4.1.2. Canada
2.4.2. Europe
2.4.2.1. UK
2.4.2.2. Germany
2.4.2.3. France
2.4.2.4. Italy
2.4.2.5. Spain
2.4.2.6. Poland
2.4.2.7. Russia
2.4.2.8. Ukraine
2.4.2.9. Belarus
2.4.2.10. Turkey
2.4.3. Asia Pacific
2.4.3.1. Japan
2.4.3.2. China
2.4.3.3. India
2.4.3.4. Australia
2.4.3.5. South Korea
2.4.4. Latin America
2.4.4.1. Brazil
2.4.4.2. Mexico
2.4.4.3. Argentina
2.4.4.4. Colombia
2.4.5. MEA
2.4.5.1. Saudi Arabia
2.4.5.2. South Africa
2.4.5.3. UAE
Chapter 3. Competitive Landscape
3.1. Recent Developments & Impact Analysis, By Key Market Participants
3.2. Company/Competition Categorization
3.2.1. Innovators
3.3. Vendor Landscape
3.3.1. List of key distributors and channel partners
3.3.2. Key customers
3.3.3. Key company market share analysis, 2021
3.3.4. Abbott Laboratories
3.3.4.1. Company overview
3.3.4.2. Financial performance
3.3.4.3. Modality benchmarking
3.3.4.4. Strategic initiatives
3.3.5. Medtronic
3.3.5.1. Company overview
3.3.5.2. Financial performance
3.3.5.3. Modality benchmarking
3.3.5.4. Strategic initiatives
3.3.6. F. Hoffmann-La Roche Ltd
3.3.6.1. Company overview
3.3.6.2. Financial performance
3.3.6.3. Modality benchmarking
3.3.6.4. Strategic initiatives
3.3.7. Ascensia Diabetes Care
3.3.7.1. Company overview
3.3.7.2. Financial performance
3.3.7.3. Modality benchmarking
3.3.7.4. Strategic initiatives
3.3.8. Lifescan Inc
3.3.8.1. Company overview
3.3.8.2. Financial performance
3.3.8.3. Modality benchmarking
3.3.8.4. Strategic initiatives
3.3.9. Dexcom, Inc
3.3.9.1. Company overview
3.3.9.2. Financial performance
3.3.9.3. Modality benchmarking
3.3.9.4. Strategic initiatives
3.3.10. Sanofi
3.3.10.1. Company overview
3.3.10.2. Financial performance
3.3.10.3. Modality benchmarking
3.3.10.4. Strategic initiatives
3.3.11. Elly Lilly and Company
3.3.11.1. Company overview
3.3.11.2. Financial performance
3.3.11.3. Modality benchmarking
3.3.11.4. Strategic initiatives
3.3.12. B Braun Melsungen AG
3.3.12.1. Company overview
3.3.12.2. Financial performance
3.3.12.3. Modality benchmarking
3.3.12.4. Strategic initiatives
3.3.13. Nipro
3.3.13.1. Company overview
3.3.13.2. Financial performance
3.3.13.3. Modality benchmarking
3.3.13.4. Strategic initiatives
3.3.14. Nova Biomedical
3.3.14.1. Company overview
3.3.14.2. Financial performance
3.3.14.3. Modality benchmarking
3.3.14.4. Strategic initiatives
3.3.15. Trividia Health, Inc.
3.3.15.1. Company overview
3.3.15.2. Financial performance
3.3.15.3. Modality benchmarking
3.3.15.4. Strategic initiatives
3.3.16. Prodigy Diabetes Care, LLC
3.3.16.1. Company overview
3.3.16.2. Financial performance
3.3.16.3. Modality benchmarking
3.3.16.4. Strategic initiatives
3.3.17. EKF Diagnostics
3.3.17.1. Company overview
3.3.17.2. Financial performance
3.3.17.3. Modality benchmarking3.
3.3.17.4. Strategic initiatives

Table of Contents - Blood Glucose Monitors

Chapter 1. Industry Trends Analysis
1.1. Executive Summary
1.2. Market Lineage Outlook
1.2.1. Parent market outlook
1.2.2. Related/ancillary market outlook
1.3. Penetration & Growth Prospect Mapping
1.4. Industry Value Chain Analysis
1.4.1. Reimbursement framework
1.5. Market Dynamics
1.5.1. Market driver analysis
1.5.1.1. Rising geriatric population worldwide
1.5.1.2. Increasing number of diabetes patients
1.5.1.3. Increasing awareness about diabetes preventive care
1.5.2. Market restraint analysis
1.5.2.1. High cost of devices
1.6. Systems Market Analysis Tools
1.6.1. Industry Analysis - Porter’s
1.6.1.1. Supplier power
1.6.1.2. Buyer power
1.6.1.3. Substitution threat
1.6.1.4. Threat of new entrant
1.6.1.5. Competitive rivalry
1.6.2. PESTEL Analysis
1.6.2.1. Political landscape
1.6.2.2. Technological landscape
1.6.2.3. Economic landscape
1.6.3. Major Deals & Strategic Alliances Analysis
1.6.4. Market Entry Strategies
Chapter 2. Blood Glucose Monitors Statistics
2.1. Blood Glucose Monitors Market Analysis and Segment Forecasts, by Product, 2017-2030
2.1.1. Self-monitoring devices
2.1.1.1. Blood glucose meter
2.1.1.2. Testing strips
2.1.1.3. Lancets
2.1.2. Continuous glucose monitoring devices
2.1.2.1. Sensor
2.1.2.2. Transmitter and receiver
2.1.2.3. Insulin pumps
2.2. Blood Glucose Monitors Market Analysis and Segment Forecasts, by End-use, 2017-2030
2.2.1. Hospitals
2.2.2. Homecare
2.2.3. Diagnostic centers
2.3. Blood Glucose Monitors Market Estimates & Forecasts, by Region, 2017 - 2030
2.3.1. North America
2.3.1.1. U.S.
2.3.1.2. Canada
2.3.2. Europe
2.3.2.1. UK
2.3.2.2. Germany
2.3.2.3. France
2.3.2.4. Italy
2.3.2.5. Spain
2.3.2.6. Poland
2.3.2.7. Russia
2.3.2.8. Ukraine
2.3.2.9. Belarus
2.3.2.10. Turkey
2.3.3. Asia Pacific
2.3.3.1. Japan
2.3.3.2. China
2.3.3.3. India
2.3.3.4. Australia
2.3.3.5. South Korea
2.3.4. Latin America
2.3.4.1. Brazil
2.3.4.2. Mexico
2.3.4.3. Argentina
2.3.4.4. Colombia
2.3.5. MEA
2.3.5.1. Saudi Arabia
2.3.5.2. South Africa
2.3.5.3. UAE

Table of Contents - Point of care glucose testing

Chapter 1. Industry Trends Analysis
1.1. Executive Summary
1.2. Market Lineage Outlook
1.2.1. Parent market outlook
1.2.2. Related/ancillary market outlook
1.3. Penetration & Growth Prospect Mapping
1.4. Industry Value Chain Analysis
1.4.1. Reimbursement framework
1.5. Market Dynamics
1.5.1. Market driver analysis
1.5.1.1. Rising geriatric population worldwide
1.5.1.2. Increasing number of diabetes patients
1.5.1.3. Increasing awareness about diabetes preventive care
1.5.2. Market restraint analysis
1.5.2.1. High cost of devices
1.6. Systems Market Analysis Tools
1.6.1. Industry Analysis - Porter’s
1.6.1.1. Supplier power
1.6.1.2. Buyer power
1.6.1.3. Substitution threat
1.6.1.4. Threat of new entrant
1.6.1.5. Competitive rivalry
1.6.2. PESTEL Analysis
1.6.2.1. Political landscape
1.6.2.2. Technological landscape
1.6.2.3. Economic landscape
1.6.3. Major Deals & Strategic Alliances Analysis
1.6.4. Market Entry Strategies
Chapter 2. Point of Care Glucose Testing Statistics
2.1. Point-of-care Glucose Testing Market Analysis and Segment Forecasts, by Product, 2017 to 2030
2.1.1. Accu Check Aviva Meter
2.1.2. Onetouch Verio Flex
2.1.3. i-STAT
2.1.4. Freestyle Lite
2.1.5. Bayer CONTOUR Blood Glucose Monitoring System
2.1.6. True Metrix
2.1.7. Accu-Chek Inform II
2.1.8. StatStrip
2.1.9. Others
2.2. Point-of-care Glucose Testing Market Estimates & Forecasts, by Region, 2017 - 2030
2.2.1. North America
2.2.1.1. U.S.
2.2.1.2. Canada
2.2.2. Europe
2.2.2.1. UK
2.2.2.2. Germany
2.2.2.3. France
2.2.2.4. Italy
2.2.2.5. Spain
2.2.2.6. Poland
2.2.2.7. Russia
2.2.2.8. Ukraine
2.2.2.9. Belarus
2.2.2.10. Turkey
2.2.3. Asia Pacific
2.2.3.1. Japan
2.2.3.2. China
2.2.3.3. India
2.2.3.4. Australia
2.2.3.5. South Korea
2.2.4. Latin America
2.2.4.1. Brazil
2.2.4.2. Mexico
2.2.4.3. Argentina
2.2.4.4. Colombia
2.2.5. MEA
2.2.5.1. Saudi Arabia
2.2.5.2. South Africa
2.2.5.3. UAE

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.